rs28371763

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2

The NM_017460.6(CYP3A4):​c.*948A>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0145 in 152,300 control chromosomes in the GnomAD database, including 26 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.014 ( 26 hom., cov: 32)
Failed GnomAD Quality Control

Consequence

CYP3A4
NM_017460.6 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.545

Publications

7 publications found
Variant links:
Genes affected
CYP3A4 (HGNC:2637): (cytochrome P450 family 3 subfamily A member 4) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by glucocorticoids and some pharmacological agents. This enzyme is involved in the metabolism of approximately half the drugs in use today, including acetaminophen, codeine, cyclosporin A, diazepam, erythromycin, and chloroquine. The enzyme also metabolizes some steroids and carcinogens. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Previously another CYP3A gene, CYP3A3, was thought to exist; however, it is now thought that this sequence represents a transcript variant of CYP3A4. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2020]
CYP3A4 Gene-Disease associations (from GenCC):
  • vitamin D-dependent rickets, type 3
    Inheritance: Unknown, AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0145 (2208/152300) while in subpopulation SAS AF = 0.0352 (170/4832). AF 95% confidence interval is 0.0309. There are 26 homozygotes in GnomAd4. There are 1099 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 2208 Unknown,AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_017460.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP3A4
NM_017460.6
MANE Select
c.*948A>T
3_prime_UTR
Exon 13 of 13NP_059488.2
CYP3A4
NM_001202855.3
c.*948A>T
3_prime_UTR
Exon 13 of 13NP_001189784.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP3A4
ENST00000651514.1
MANE Select
c.*948A>T
3_prime_UTR
Exon 13 of 13ENSP00000498939.1P08684
CYP3A4
ENST00000859201.1
c.*948A>T
3_prime_UTR
Exon 14 of 14ENSP00000529260.1
CYP3A4
ENST00000859200.1
c.*948A>T
3_prime_UTR
Exon 13 of 13ENSP00000529259.1

Frequencies

GnomAD3 genomes
AF:
0.0145
AC:
2207
AN:
152182
Hom.:
26
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00335
Gnomad AMI
AF:
0.0197
Gnomad AMR
AF:
0.00949
Gnomad ASJ
AF:
0.0199
Gnomad EAS
AF:
0.000578
Gnomad SAS
AF:
0.0349
Gnomad FIN
AF:
0.0170
Gnomad MID
AF:
0.0854
Gnomad NFE
AF:
0.0209
Gnomad OTH
AF:
0.0158
GnomAD4 exome
Data not reliable, filtered out with message: AC0;AS_VQSR
AC:
0
AN:
0
Hom.:
0
Cov.:
0
AC XY:
0
AN XY:
0
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AC:
0
AN:
0
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome
AF:
0.0145
AC:
2208
AN:
152300
Hom.:
26
Cov.:
32
AF XY:
0.0148
AC XY:
1099
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.00337
AC:
140
AN:
41564
American (AMR)
AF:
0.00947
AC:
145
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0199
AC:
69
AN:
3468
East Asian (EAS)
AF:
0.000579
AC:
3
AN:
5178
South Asian (SAS)
AF:
0.0352
AC:
170
AN:
4832
European-Finnish (FIN)
AF:
0.0170
AC:
181
AN:
10618
Middle Eastern (MID)
AF:
0.0884
AC:
26
AN:
294
European-Non Finnish (NFE)
AF:
0.0209
AC:
1423
AN:
68014
Other (OTH)
AF:
0.0156
AC:
33
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
105
210
315
420
525
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0167
Hom.:
18
Bravo
AF:
0.0139
Asia WGS
AF:
0.0140
AC:
48
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
1.7
DANN
Benign
0.55
PhyloP100
0.55
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28371763; hg19: chr7-99354808; API